Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Moodys
Medtronic
McKesson
AstraZeneca
McKinsey
Healthtrust
Johnson and Johnson
Colorcon

Generated: December 11, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 014122

« Back to Dashboard

NDA 014122 describes PROTOPAM CHLORIDE, which is a drug marketed by Baxter Hlthcare Corp and Wyeth Ayerst and is included in two NDAs. It is available from one supplier. Additional details are available on the PROTOPAM CHLORIDE profile page.

The generic ingredient in PROTOPAM CHLORIDE is pralidoxime chloride. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pralidoxime chloride profile page.

Summary for 014122

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength500MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Moodys
Farmers Insurance
Citi
Cantor Fitzgerald
Daiichi Sankyo
Novartis
Baxter
UBS
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot